Share

Clinton clinches Aids deal

The Clinton Foundation announced Tuesday that it has reached agreements with drug companies to reduce the costs of some HIV/Aids drugs in developing countries.

The foundation said drug makers agreed to lower the price of drugs to fight HIV that is resistant to initial treatment, and to make a once-a-day HIV/Aids pill available for less than $1 a day, the Associated Press reported.

The deals on the drugs to fight resistant HIV, reached with generic drug makers Cipla Ltd. and Matrix Laboratories Ltd., are expected to achieve average savings of 50 percent in middle-income countries and 25 percent in low-income countries, said former US President Bill Clinton.

The agreement on the $1 once-a-day pills that combine the drugs efavirenz, lamivudine and tenofovir is 45 percent less than the current rate available for low-income countries and 67 percent less than the current price for many middle-income countries, the AP reported. – (HealthDayNews)

Read more:
HIV/Aids Centre

May 2007

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE